Drug · DIN 02365871
TACTUPUMP
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 2, 2014; first marketed May 13, 2011.
- Drug Identification Number (DIN)
- 02365871
- Company (DIN owner)
- Galderma Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Gel
- Route
- Topical
- Therapeutic class (ATC)
- Adapalene, combinations D10AD53
- Class
- Human
- Record last updated
- June 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ADAPALENE | 0.1 % | W/W |
| BENZOYL PEROXIDE | 2.5 % | W/W |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 22, 2013: NOC 14842Supplement to a New Drug Submission (SNDS) · Brand name change
- March 21, 2011: NOC 12204New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “tactupump”. A notice may cover another product or only some lots: read it to see what it covers.
- Tactupump (2017-07-17)October 4, 2017 · Drugs · Product safety · Type III
- Tactupump Forte (2017-07-17)October 4, 2017 · Drugs · Product safety · Type III